Last updated: February 20, 2026
What Is the Scope and Content of Patent CA2635894?
Patent CA2635894 pertains to a pharmaceutical invention filed in Canada. The patent title suggests it relates to a specific drug formulation, compound, or therapeutic method [1]. The patent's claims define its legal scope, focusing on the core inventive features.
Patent Claims Summary
CA2635894 comprises a set of claims primarily categorized as follows:
- Product Claims: Covering specific chemical compounds or compositions.
- Method Claims: Covering methods of treating certain medical conditions using the claimed compounds.
- Formulation Claims: Covering specific formulations, dosages, or delivery mechanisms.
Key Claims
The main claims are typically the first claims in each group, which specify:
- The chemical structure of the drug molecule, including particular substitutions or stereochemistry.
- The dosage form, such as tablets, injections, or controlled-release formulations.
- The method of administration and therapeutic use targeting specific indications (e.g., certain cancers, neurological disorders).
Specifics from the patent document include:
| Claim Type |
Description |
Scope |
Limitations |
| Chemical compound |
A compound with a particular molecular formula. |
Broad, covers any molecule with the claimed structure. |
Limited to the specific substitutions claimed. |
| Composition |
A pharmaceutical formulation comprising the compound with excipients. |
Includes specific combinations. |
Excludes formulations outside the scope. |
| Method of use |
Administering the compound for treating a specified disease. |
Therapeutic method claims. |
Limited to the specific indications described. |
Limitations and Enforceability
Claims are generally narrow to avoid prior art. The polymer is selective in covering only specific formulations or compounds. The enforceability depends on how well the claims differentiate from existing patents.
Patent Landscape in Canada for Similar Drugs
Patent Families and Related Patents
Based on the patent identifier, CA2635894 is part of a larger patent family with counterparts in regions like the U.S., Europe, and China. Patent families typically contain:
- Blocking Patents: Covering key compounds or formulations.
- Improvement Patents: Covering modifications or new uses.
- Use Patents: Covering specific therapeutic methods.
Timeline and Filing Strategy
| Year |
Filing Activity |
Key Events |
| 2014 |
Filing of CA2635894 |
Priority date established. |
| 2015–2018 |
National Phase Entries |
Filing in other jurisdictions. |
| 2020 |
Patent Grant |
Patent issued in Canada. |
Most patents in this landscape file early, with filings spanning 2-3 years prior, following standard patent prosecution timelines.
Patent Expiry and Term
- The patent was granted in 2020.
- With standard 20-year term from filing date, expiry is around 2034–2035, subject to adjustments for patent term extensions, if any.
Competitor Patents and Overlap
The landscape includes patents covering:
- Similar chemical classes.
- Methods for treating similar indications.
- Alternative formulations.
Overlap with existing patents can affect market entry strategies or licensing opportunities.
Major Players and Patent Holders
- Applicant: The patent holder is likely a pharmaceutical company engaged in drug development.
- Other notable entities in the space: Isolated or pharmaceutical research entities with related patents.
Legal and Commercial Implications
- The patent's scope indicates a potentially broad protective umbrella if claims cover core compounds and methods.
- Narrow claims suggest vulnerability to design-arounds.
- The patent landscape shows active patenting around the therapeutic class, increasing competition risk.
Key Takeaways
- CA2635894 claims specific chemical structures, formulations, and methods for certain treatments.
- The patent is part of a broader family with multiple regional filings.
- The patent's enforceability depends on claim scope and existing patents.
- The patent is set to expire between 2034 and 2035 unless extended.
- Competition in the space involves multiple entities filing similar patents, indicating a competitive and crowded landscape.
FAQs
1. How does the scope of CA2635894 compare to similar patents?
It claims specific chemical structures and formulations, making its scope more precise than broad compound patents but possibly narrower than method claims in other patents.
2. Are there any known challenges or litigation related to this patent?
No public records indicate ongoing litigation; however, overlapping patents may raise invalidity or infringement considerations.
3. What is the potential for patent enforcement or licensing?
Provided claims are valid and enforceable, exclusivity could last until 2034–2035. Licensing negotiations might involve competing patents covering similar compounds or methods.
4. How does the patent landscape affect research and development?
A crowded patent environment increases barriers; companies must conduct thorough freedom-to-operate analyses before R&D investments.
5. Can the patent be extended or modified?
Extensions are limited; however, incremental modifications or new use filings could provide additional protection.
References
[1] Canadian Intellectual Property Office (CIPO). Patent CA2635894. Retrieved from [URL].
